![]() |
市場調査レポート
商品コード
1789251
マイクロキャリアの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年Microcarriers Market Size, Share, and Growth Analysis, By Product (Consumables, Equipment), By Application (Biopharmaceutical Production, Therapy Type), By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
マイクロキャリアの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年08月07日
発行: SkyQuest
ページ情報: 英文 172 Pages
納期: 3~5営業日
|
マイクロキャリアの世界市場規模は2023年に17億8,000万米ドルと評価され、2024年の18億9,000万米ドルから2032年には29億7,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは5.75%で成長する見通しです。
マイクロキャリアの世界市場は、細胞ベースのワクチン需要の急増、再生医療への幅広い応用、シングルユースバイオリアクターの普及に後押しされ、力強い成長を遂げています。幹細胞研究における技術革新は、ワクチンや治療法の大量生産を容易にするため、この拡大をさらに後押ししています。幹細胞治療と組織工学への多額の投資は、自動化された大規模バイオプロセスへのシフトとともに、この勢いに貢献しています。マイクロキャリアによる個別化医療や3D細胞培養法の動向の高まりは、バイオ医薬品やライフサイエンス分野の収益見通しを高めています。しかし、一部の新興市場では、高い生産コスト、スケーラビリティの問題、複雑な規制、技術的専門性の低さなどの課題が、より広範な市場浸透を妨げており、地域開拓や将来予測に影響を与えています。
Global Microcarrier Market size was valued at USD 1.78 Billion in 2023 and is poised to grow from USD 1.89 Billion in 2024 to USD 2.97 Billion by 2032, growing at a CAGR of 5.75% during the forecast period (2025-2032).
The global microcarrier market is experiencing robust growth fueled by the surging demand for cell-based vaccines, broader applications in regenerative medicine, and the increasing popularity of single-use bioreactors. Innovations in stem cell research further propel this expansion, as microcarriers facilitate large-scale production of vaccines and therapies. Significant investments in stem cell therapy and tissue engineering contribute to this momentum, alongside a shift towards automated, large-scale bioprocessing. The rising trend of personalized medicine and 3D cell culture methods with microcarriers is enhancing revenue prospects in the biopharmaceutical and life sciences fields. However, challenges such as high production costs, scalability issues, complex regulations, and low technological expertise in certain emerging markets hinder broader market penetration, impacting regional development and future projections.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microcarrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microcarrier Market Segments Analysis
Global Microcarriers Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Consumables and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Therapy Type, Cell Type and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes and Cell Banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Microcarrier Market
The rising prevalence of infectious diseases, coupled with the urgent demand to vaccinate large populations, is driving a significant shift among manufacturers and researchers toward the adoption of microcarriers. These small particles facilitate the growth of cells at high density, enhancing both yield and efficiency in production processes. Microcarriers have become indispensable in modern large-scale vaccine manufacturing as they effectively immobilize virus-producing cells, ensuring a more streamlined and effective production environment. This shift underscores the importance of microcarriers in addressing public health challenges and meeting global vaccination needs.
Restraints in the Global Microcarrier Market
The Global Microcarrier market faces significant challenges due to the substantial investment required for process-specific bioreactors, coating materials, and process optimization tools. These financial burdens can be prohibitive for small laboratories and emerging biotech companies, limiting their ability to adopt microcarrier technologies. Additionally, costs related to maintenance, employee training, and regulatory compliance further exacerbate the situation, making it difficult for organizations in cost-sensitive environments to access and implement these advanced solutions. This combination of high initial and ongoing expenses restricts the growth and adoption of microcarrier systems in the broader market.
Market Trends of the Global Microcarrier Market
The global microcarrier market is witnessing significant growth driven by the rising adoption of single-use bioreactors, which are revolutionizing the manufacturing processes for biologics and cell therapy products. This combination enhances operational flexibility while minimizing the risks of contamination, thereby streamlining production with reduced cleaning and validation costs. As microcarriers facilitate high-density cell cultures within a closed, sterile environment, they contribute to decreased production timelines and improved efficiency in the pharmaceutical and biotechnology industries. Consequently, this trend fosters innovative approaches to cell-based product manufacturing, positioning microcarriers as essential components in the evolution of biomanufacturing technologies.